Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $54.24
- 52-wk high
- $54.27
- High
- $54.27
- 52-wk low
- $26.17
- Low
- $52.51
- Prev close
- $53.26
Smart money
Earnings
Earnings came in 63.2% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $106.7M | $125.2M | $81.4M | $102.8M |
| Cost of what it sold | $39.4M | $55.1M | $35.6M | $39.9M |
| Gross profit | $67.3M | $70.1M | $45.8M | $62.9M |
| What it spent | ||||
| Research and development | $1.5M | $1.5M | $1.8M | $1.7M |
| Sales and admin | $34.2M | $33.5M | $32.5M | $34.5M |
| Other operating costs | $2.5M | $2.8M | $1.6M | $5.9M |
| Total operating expenses | $38.2M | $37.8M | $35.9M | $42.1M |
| What was left | ||||
| Operating profit | $29.0M | $32.3M | $10.0M | $20.8M |
| Interest on debt | $1.8M | $1.8M | $1.9M | $2.0M |
| Profit before tax | $27.8M | $6.6M | $8.5M | $19.4M |
| Tax | $5.2M | $4.1M | $2.4M | $3.5M |
| Net profit | $20.7M | $637.0K | $4.2M | $15.4M |
| EBITDA | $45.3M | $24.4M | $25.6M | $34.8M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
IMAX (NYSE: IMAX) Gelfond to sell 151K shares via preset plan
NeutralAug 18Just 1% of China’s Screens Accounted for 53% of a Film’s Gross
BullishAug 17The Odyssey breathes new life into Imax Corp.
NeutralAug 17